Analyst Consensus ?
ConsensusBuy37 ratings
Bullish2362.2%
Neutral1335.1%
Bearish12.7%
FN2 Earnings Intelligence
Lockheed Martin Corporation (LMT) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Oct 27, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Morgan Stanley | Overweight | Equal Weight | Upgrade | Oct 26, 2026 |
| UBS | Buy | Buy | Maintain | Oct 23, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Oct 23, 2026 |
| Citigroup | Buy | Buy | Maintain | Oct 23, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Oct 23, 2026 |
| Bernstein | Market Perform | Market Perform | Maintain | Oct 14, 2026 |
| TD Cowen | Hold | Hold | Maintain | Oct 9, 2026 |
| Susquehanna | Positive | Positive | Maintain | Apr 24, 2026 |
| Jefferies | Hold | Hold | Maintain | Apr 7, 2026 |
| Goldman Sachs | Sell | Sell | Maintain | Feb 2, 2026 |
| Truist Securities | Buy | Hold | Upgrade | Jan 9, 2026 |
| JP Morgan | Neutral | Overweight | Downgrade | Dec 19, 2025 |
| Baird | Outperform | Outperform | Maintain | Oct 6, 2025 |
| B of A Securities | Neutral | Neutral | Maintain | Aug 21, 2025 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Apr 8, 2025 |
| Deutsche Bank | Hold | Buy | Downgrade | Jan 2, 2025 |
| Credit Suisse | Outperform | Outperform | Maintain | Apr 19, 2023 |
| DZ Bank | Buy | Hold | Upgrade | Jan 30, 2023 |
| Wolfe Research | Perform | Peer Perform | Maintain | Oct 11, 2022 |
| Cowen & Co. | Market Perform | Outperform | Downgrade | Sep 29, 2021 |
| Argus Research | Buy | Buy | Maintain | Jul 24, 2020 |
| Seaport Global | Buy | Buy | Maintain | May 19, 2020 |
| Buckingham Research | Buy | Buy | Maintain | Feb 7, 2020 |
| Buckingham | Buy | Buy | Maintain | Feb 7, 2020 |
| Stifel Nicolaus | Buy | Buy | Maintain | Jan 30, 2020 |
| Stifel | Buy | Buy | Maintain | Jan 30, 2020 |
| Alembic Global | Neutral | Overweight | Downgrade | Jan 29, 2020 |
| Vertical Research | Buy | Hold | Upgrade | Jan 10, 2019 |
| Berenberg | Buy | Hold | Upgrade | Jul 26, 2018 |
| Bank of America | Buy | Buy | Maintain | Jul 25, 2018 |
| Argus | Buy | Hold | Upgrade | May 5, 2018 |
| Guggenheim | Buy | Buy | Maintain | Jan 20, 2016 |
| Drexel Hamilton | Buy | Buy | Maintain | Oct 21, 2015 |
| Sterne Agee CRT | Buy | Neutral | Upgrade | Aug 20, 2015 |
| Sterne Agee | Buy | Neutral | Upgrade | Aug 20, 2015 |
| FBR Capital | Outperform | Outperform | Maintain | Jun 19, 2014 |
| CRT Capital | Hold | Sell | Upgrade | Nov 30, 2012 |
Upside is calculated against the persisted previous close $635.2. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Analyst unavailable | $620 | $604.18 | -2.4% | Oct 26, 2026 |
| Morgan Stanley | Analyst unavailable | $835 | $604.18 | +31.5% | Oct 25, 2026 |
| Jefferies | Sheila Kahyaoglu | $615 | $604.18 | -3.2% | Oct 25, 2026 |
| UBS | Analyst unavailable | $692 | $594.05 | +8.9% | Oct 23, 2026 |
| Barclays | Anthony Valentini | $560 | $589.91 | -11.8% | Oct 23, 2026 |
| UBS | Gavin Parsons | $653 | $548.07 | +2.8% | Oct 16, 2026 |
| Bernstein | Analyst unavailable | $564 | $504.02 | -11.2% | Oct 14, 2026 |
| Vertical Research | Robert Stallard | $600 | $504.02 | -5.5% | Oct 14, 2026 |
| Barclays | Analyst unavailable | $554 | $507.89 | -12.8% | Oct 8, 2026 |
| Redburn Partners | Analyst unavailable | $650 | $506.63 | +2.3% | Oct 6, 2026 |
| UBS | Gavin Parsons | $674 | $525.28 | +6.1% | Sep 8, 2026 |
| Wells Fargo | Analyst unavailable | $600 | $582.65 | -5.5% | Jul 27, 2026 |
| UBS | Gavin Parsons | $581 | $578.53 | -8.5% | Jul 24, 2026 |
| Robert W. Baird | Analyst unavailable | $700 | $568.59 | +10.2% | Jul 24, 2026 |
| Morgan Stanley | Analyst unavailable | $690 | $568.59 | +8.6% | Jul 24, 2026 |
| Wells Fargo | Analyst unavailable | $575 | $535.38 | -9.5% | Jul 8, 2026 |
| Jefferies | Analyst unavailable | $575 | $504.94 | -9.5% | Jun 25, 2026 |
| Jefferies | Sheila Kahyaoglu | $595 | $513.1 | -6.3% | Apr 26, 2026 |
| Susquehanna | Analyst unavailable | $700 | $509.78 | +10.2% | Apr 24, 2026 |
| Morgan Stanley | Kristine Liwag | $653 | $512.62 | +2.8% | Apr 24, 2026 |
| RBC Capital | Analyst unavailable | $575 | $529.79 | -9.5% | Apr 24, 2026 |
| Bernstein | Douglas Harned | $654 | $620.27 | +3.0% | Feb 6, 2026 |
| Morgan Stanley | Kristine Liwag | $675 | $628.26 | +6.3% | Feb 4, 2026 |
| Goldman Sachs | Analyst unavailable | $517 | $634.22 | -18.6% | Feb 2, 2026 |
| UBS | Analyst unavailable | $663 | $634.22 | +4.4% | Feb 2, 2026 |
| Jefferies | Analyst unavailable | $630 | $634.22 | -0.8% | Feb 1, 2026 |
| Truist Financial | Analyst unavailable | $695 | $635.24 | +9.4% | Jan 30, 2026 |
| RBC Capital | Analyst unavailable | $650 | $629.08 | +2.3% | Jan 30, 2026 |
| Seaport Global | Analyst unavailable | $664 | $587.68 | +4.5% | Jan 22, 2026 |
| Susquehanna | Analyst unavailable | $660 | $568.75 | +3.9% | Jan 15, 2026 |
| UBS | Analyst unavailable | $580 | $565.8 | -8.7% | Jan 15, 2026 |
| Jefferies | Analyst unavailable | $540 | $548.24 | -15.0% | Jan 12, 2026 |
| Bernstein | Analyst unavailable | $586 | $549.78 | -7.7% | Jan 12, 2026 |
| Truist Financial | Analyst unavailable | $605 | $518.44 | -4.8% | Jan 9, 2026 |
| Morgan Stanley | Kristine Liwag | $543 | $484.42 | -14.5% | Dec 16, 2025 |
| UBS | Analyst unavailable | $513 | $489.5 | -19.2% | Oct 22, 2025 |
| UBS | Analyst unavailable | $545 | $495.15 | -14.2% | Oct 20, 2025 |
| Truist Financial | Michael Ciarmoli | $500 | $500.18 | -21.3% | Oct 15, 2025 |
| Morgan Stanley | Analyst unavailable | $630 | $505.18 | -0.8% | Oct 15, 2025 |
| Susquehanna | Analyst unavailable | $590 | $514.02 | -7.1% | Oct 9, 2025 |
| Deutsche Bank | Analyst unavailable | $519 | $511.07 | -18.3% | Oct 8, 2025 |
| Robert W. Baird | Analyst unavailable | $550 | $504.49 | -13.4% | Oct 6, 2025 |
| Vertical Research | Robert Stallard | $460 | $410.52 | -27.6% | Jul 22, 2025 |
| Bernstein | Douglas Harned | $551 | $473.57 | -13.3% | Jul 14, 2025 |
| Truist Financial | Michael Ciarmoli | $554 | $467.51 | -12.8% | Jul 11, 2025 |
| RBC Capital | Analyst unavailable | $480 | $442.28 | -24.4% | Mar 27, 2025 |
| Wells Fargo | Analyst unavailable | $476 | $473.65 | -25.1% | Mar 7, 2025 |
| Robert W. Baird | Peter Arment | $540 | $463.96 | -15.0% | Jan 14, 2025 |
| Bernstein | Douglas Harned | $548 | $468.05 | -13.7% | Jan 10, 2025 |
| Jefferies | Sheila Kahyaoglu | $580 | $546.8 | -8.7% | Oct 30, 2024 |
| Jefferies | Sheila Kahyaoglu | $590 | $571.1 | -7.1% | Oct 24, 2024 |
| Susquehanna | Charles Minervino | $695 | $576.98 | +9.4% | Oct 23, 2024 |
| RBC Capital | Ken Herbert | $665 | $576.98 | +4.7% | Oct 23, 2024 |
| Goldman Sachs | Noah Poponak | $434 | $576.98 | -31.7% | Oct 23, 2024 |
| Deutsche Bank | Scott Deuschle | $611 | $576.98 | -3.8% | Oct 23, 2024 |
| RBC Capital | Ken Herbert | $675 | $605.13 | +6.3% | Oct 7, 2024 |
| Deutsche Bank | Scott Deuschle | $620 | $603.79 | -2.4% | Oct 3, 2024 |
| Melius Research | Robert Spingarn | $704 | $568.1 | +10.8% | Sep 3, 2024 |
| Morgan Stanley | Kristine Liwag | $599 | $551.62 | -5.7% | Aug 9, 2024 |
| RBC Capital | Ken Herbert | $600 | $548.77 | -5.5% | Aug 5, 2024 |
| Bank of America Securities | Ronald Epstein | $635 | $537.66 | -0.0% | Jul 31, 2024 |
| Barclays | David Strauss | $505 | $527.64 | -20.5% | Jul 30, 2024 |
| Deutsche Bank | Scott Deuschle | $600 | $526.72 | -5.5% | Jul 26, 2024 |
| RBC Capital | Ken Herbert | $500 | $503.24 | -21.3% | Jul 24, 2024 |
| Wells Fargo | Matthew Akers | $480 | $459.14 | -24.4% | Apr 25, 2024 |
| Deutsche Bank | Scott Deuschle | $487 | $459.14 | -23.3% | Apr 24, 2024 |
| Jefferies | Sheila Kahyaoglu | $485 | $453.08 | -23.6% | Apr 15, 2024 |
| Credit Suisse | Scott Deuschle | $510 | $464.51 | -19.7% | Feb 7, 2023 |
| Goldman Sachs | Noah Poponak | $332 | $461.74 | -47.7% | Jan 13, 2023 |
| Morgan Stanley | Analyst unavailable | $542 | $485.19 | -14.7% | Dec 15, 2022 |
| J.P. Morgan | Analyst unavailable | $505 | $482.67 | -20.5% | Dec 12, 2022 |
| RBC Capital | Ken Herbert | $460 | $426.41 | -27.6% | Aug 30, 2022 |
| Susquehanna | Charles Minervino | $539 | $413.81 | -15.1% | Jul 30, 2022 |
| Wells Fargo | Matthew Akers | $406 | $413.81 | -36.1% | Jul 30, 2022 |
| Wells Fargo | Matthew Akers | $406 | $395.22 | -36.1% | Jul 20, 2022 |
| Morgan Stanley | Analyst unavailable | $525 | $416.37 | -17.3% | Jul 12, 2022 |
| Wells Fargo | Matthew Akers | $496 | $445.79 | -21.9% | Apr 25, 2022 |
| Argus Research | John Eade | $500 | $453.87 | -21.3% | Apr 20, 2022 |
| UBS | Myles Walton | $465 | $426.18 | -26.8% | Mar 20, 2022 |
| Jefferies | Sheila Kahyaoglu | $505 | $439.04 | -20.5% | Mar 12, 2022 |
| Wells Fargo | Matthew Akers | $486 | $444.36 | -23.5% | Mar 10, 2022 |
| Wolfe Research | Michael Maugeri | $467 | $458.15 | -26.5% | Mar 5, 2022 |
| Bank of America Securities | Ronald Epstein | $410 | $386.42 | -35.5% | Jan 27, 2022 |
| Wells Fargo | Matthew Akers | $400 | $391.24 | -37.0% | Jan 26, 2022 |
| J.P. Morgan | Seth Seifman | $420 | $388.56 | -33.9% | Jan 26, 2022 |
| Bernstein | Douglas Harned | $401 | $388.56 | -36.9% | Jan 26, 2022 |
| Susquehanna | Charles Minervino | $445 | $388.56 | -29.9% | Jan 26, 2022 |
| Wells Fargo | Matthew Akers | $379 | $372.62 | -40.3% | Jan 15, 2022 |
| Goldman Sachs | Noah Poponak | $402 | $339.04 | -36.7% | Sep 23, 2021 |
| Credit Suisse | Robert Spingarn | $398 | $366.46 | -37.3% | Jul 27, 2021 |
| Stifel Nicolaus | Joseph DeNardi | $468 | $359.93 | -26.3% | Jul 26, 2021 |
Track every rating change on LMT the moment it posts. Free to start.
Start freeOne email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.